Analystreport

CASI Pharmaceuticals, Inc. (NASDAQ: CASI) is now covered by analysts at Mizuho. They set a "buy" rating and a $3.80 price target on the stock.

CASI Pharmaceuticals, Inc. - Ordinary Shares  (CASI) 
Last casi pharmaceuticals, inc. - ordinary shares earnings: 11/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: casipharmaceuticals.com/investor-relations